341 related articles for article (PubMed ID: 18539578)
1. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
[TBL] [Abstract][Full Text] [Related]
2. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.
Szapary L; Horvath B; Marton Z; Alexy T; Kesmarky G; Habon T; Szots M; Koltai K; Juricskay I; Czopf J; Toth K
CNS Drugs; 2004; 18(3):165-72. PubMed ID: 14871160
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of atorvastatin on hemorheologic parameters and endothelial dysfunction in patients with hypercholesterolemia. Lower is better?
Habon T; Horvath B; Szapary L; Toth K
Clin Hemorheol Microcirc; 2008; 40(4):325-6. PubMed ID: 19126996
[No Abstract] [Full Text] [Related]
4. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients.
Dujovne CA; Harris WS; Altman R; Overhiser RW; Black DM
Am J Cardiol; 2000 Feb; 85(3):350-3. PubMed ID: 11078305
[TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on hemorheological parameters in rabbits fed on a normal diet.
Cefle K; Tamer S; Kaymaz AA; Balci M; Ahmetov S; Palanduz S; Ozturk S; Salmayenli N; Onar V
Clin Hemorheol Microcirc; 2002; 26(4):265-71. PubMed ID: 12122232
[TBL] [Abstract][Full Text] [Related]
6. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia.
Frost RJ; Otto C; Geiss HC; Schwandt P; Parhofer KG
Am J Cardiol; 2001 Jan; 87(1):44-8. PubMed ID: 11137832
[TBL] [Abstract][Full Text] [Related]
8. High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine.
van der Loo B; Spring S; Koppensteiner R
Clin Hemorheol Microcirc; 2011; 47(4):241-51. PubMed ID: 21654053
[TBL] [Abstract][Full Text] [Related]
9. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
10. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment.
Banyai S; Banyai M; Falger J; Jansen M; Alt E; Derfler K; Koppensteiner R
Atherosclerosis; 2001 Dec; 159(2):513-9. PubMed ID: 11730833
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease.
Tekin A; Tekin G; Güzelsoy D; Kaya A; Gürel CV; Yiğit Z; Ulutin T
Am J Cardiol; 2004 Jul; 94(2):206-9. PubMed ID: 15246903
[TBL] [Abstract][Full Text] [Related]
13. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
14. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
[TBL] [Abstract][Full Text] [Related]
15. [Effect of atorvastatin on hemorheological parameters in patients with arterial hypertension with dyslipidemia].
Abrashkina ED; Shaalali N; Pakhrova OA; Shutemova EA; Nazarova OA
Kardiologiia; 2010; 50(5):25-8. PubMed ID: 20831044
[TBL] [Abstract][Full Text] [Related]
16. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
Kuryata OV; Yegorova YV
Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
[TBL] [Abstract][Full Text] [Related]
17. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
